Selected research
Industry Research
Brucella Melitensis Vaccine Industry Research Report 2026
Market perspective
The global Brucella Melitensis Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Brucella Melitensis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Brucella Melitensis Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Brucella Melitensis Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Brucella Melitensis Vaccine include Jinyu, VETAL Animal Health Products Inc., Onderstepoort, MSD Animal Health, JOVAC, Hester Biosciences Limited, Dollvet, CZ Veterinaria and Antigen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Brucella Melitensis Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Brucella Melitensis Vaccine Market by Company
Jinyu
VETAL Animal Health Products Inc.
Onderstepoort
MSD Animal Health
JOVAC
Hester Biosciences Limited
Dollvet
CZ Veterinaria
Antigen
Brucella Melitensis Vaccine Segment by Type
Live Vaccines
Attenuated Vaccines
Brucella Melitensis Vaccine Segment by Application
Commercial Farming Enterprise
Private Farming
Brucella Melitensis Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucella Melitensis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Brucella Melitensis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucella Melitensis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Brucella Melitensis Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Brucella Melitensis Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Brucella Melitensis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Live Vaccines
- Attenuated Vaccines
Applications
- Commercial Farming Enterprise
- Private Farming
Companies covered
- Jinyu
- VETAL Animal Health Products Inc.
- Onderstepoort
- MSD Animal Health
- JOVAC
- Hester Biosciences Limited
- Dollvet
- CZ Veterinaria
- Antigen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Brucella Melitensis Vaccine Market Size (2021-2032)
- 2.2.2 Global Brucella Melitensis Vaccine Sales (2021-2032)
- 2.2.3 Global Brucella Melitensis Vaccine Market Average Price (2021-2032)
- 2.3 Brucella Melitensis Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Live Vaccines
- 2.3.3 Attenuated Vaccines
- 2.4 Brucella Melitensis Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Commercial Farming Enterprise
- 2.4.3 Private Farming
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Brucella Melitensis Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Brucella Melitensis Vaccine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Brucella Melitensis Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Brucella Melitensis Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Brucella Melitensis Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Brucella Melitensis Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Brucella Melitensis Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Brucella Melitensis Vaccine, Established Date
- 3.9 Global Brucella Melitensis Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Jinyu
- 4.1.1 Jinyu Company Information
- 4.1.2 Jinyu Business Overview
- 4.1.3 Jinyu Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Jinyu Brucella Melitensis Vaccine Product Portfolio
- 4.1.5 Jinyu Recent Developments
- 4.2 VETAL Animal Health Products Inc.
- 4.2.1 VETAL Animal Health Products Inc. Company Information
- 4.2.2 VETAL Animal Health Products Inc. Business Overview
- 4.2.3 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Product Portfolio
- 4.2.5 VETAL Animal Health Products Inc. Recent Developments
- 4.3 Onderstepoort
- 4.3.1 Onderstepoort Company Information
- 4.3.2 Onderstepoort Business Overview
- 4.3.3 Onderstepoort Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Onderstepoort Brucella Melitensis Vaccine Product Portfolio
- 4.3.5 Onderstepoort Recent Developments
- 4.4 MSD Animal Health
- 4.4.1 MSD Animal Health Company Information
- 4.4.2 MSD Animal Health Business Overview
- 4.4.3 MSD Animal Health Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 MSD Animal Health Brucella Melitensis Vaccine Product Portfolio
- 4.4.5 MSD Animal Health Recent Developments
- 4.5 JOVAC
- 4.5.1 JOVAC Company Information
- 4.5.2 JOVAC Business Overview
- 4.5.3 JOVAC Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 JOVAC Brucella Melitensis Vaccine Product Portfolio
- 4.5.5 JOVAC Recent Developments
- 4.6 Hester Biosciences Limited
- 4.6.1 Hester Biosciences Limited Company Information
- 4.6.2 Hester Biosciences Limited Business Overview
- 4.6.3 Hester Biosciences Limited Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hester Biosciences Limited Brucella Melitensis Vaccine Product Portfolio
- 4.6.5 Hester Biosciences Limited Recent Developments
- 4.7 Dollvet
- 4.7.1 Dollvet Company Information
- 4.7.2 Dollvet Business Overview
- 4.7.3 Dollvet Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Dollvet Brucella Melitensis Vaccine Product Portfolio
- 4.7.5 Dollvet Recent Developments
- 4.8 CZ Veterinaria
- 4.8.1 CZ Veterinaria Company Information
- 4.8.2 CZ Veterinaria Business Overview
- 4.8.3 CZ Veterinaria Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 CZ Veterinaria Brucella Melitensis Vaccine Product Portfolio
- 4.8.5 CZ Veterinaria Recent Developments
- 4.9 Antigen
- 4.9.1 Antigen Company Information
- 4.9.2 Antigen Business Overview
- 4.9.3 Antigen Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Antigen Brucella Melitensis Vaccine Product Portfolio
- 4.9.5 Antigen Recent Developments
5 Global Brucella Melitensis Vaccine Market Scenario by Region
- 5.1 Global Brucella Melitensis Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Brucella Melitensis Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Brucella Melitensis Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Brucella Melitensis Vaccine Sales by Region: 2027-2032
- 5.3 Global Brucella Melitensis Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Brucella Melitensis Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Brucella Melitensis Vaccine Revenue by Region: 2027-2032
- 5.4 North America Brucella Melitensis Vaccine Market Facts & Figures by Country
- 5.4.1 North America Brucella Melitensis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Brucella Melitensis Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Brucella Melitensis Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Brucella Melitensis Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Brucella Melitensis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Brucella Melitensis Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Brucella Melitensis Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Brucella Melitensis Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Brucella Melitensis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Brucella Melitensis Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Brucella Melitensis Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Brucella Melitensis Vaccine Market Facts & Figures by Country
- 5.7.1 South America Brucella Melitensis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Brucella Melitensis Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Brucella Melitensis Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Brucella Melitensis Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Brucella Melitensis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Brucella Melitensis Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Brucella Melitensis Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Brucella Melitensis Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Brucella Melitensis Vaccine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Brucella Melitensis Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Brucella Melitensis Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Brucella Melitensis Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Brucella Melitensis Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Brucella Melitensis Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Brucella Melitensis Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Brucella Melitensis Vaccine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Brucella Melitensis Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Brucella Melitensis Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Brucella Melitensis Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Brucella Melitensis Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Brucella Melitensis Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Brucella Melitensis Vaccine Value Chain Analysis
- 8.1.1 Brucella Melitensis Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Brucella Melitensis Vaccine Production Mode & Process
- 8.2 Brucella Melitensis Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Brucella Melitensis Vaccine Distributors
- 8.2.3 Brucella Melitensis Vaccine Customers
9 Global Brucella Melitensis Vaccine Analyzing Market Dynamics
- 9.1 Brucella Melitensis Vaccine Industry Trends
- 9.2 Brucella Melitensis Vaccine Industry Drivers
- 9.3 Brucella Melitensis Vaccine Industry Opportunities and Challenges
- 9.4 Brucella Melitensis Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst